Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Phase II Study of Erlotinib in Patients With Locally Advanced or Metastatic Papillary Histology Renal Cell Cancer: SWOG S0317
Journal of Clinical Oncology, 11/12/09
Gordon MS et al. – Although the RECIST RR of 11% did not exceed prespecified estimates for additional study, single–agent erlotinib yielded disease control and survival outcomes of interest with an expected toxicity profile. The design of future trials of the EGFR axis in pRCC should be based on preclinical or molecular data that define appropriate patient subgroups, new drug combinations, or potentially more active alternative schedules.
Related Articles
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Outcome after thyroid surgery for metastasis from renal cell cancer
Surgery, 11/03/09
Relevance Score: 81%
Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis
Oncogene, 10/29/09
Relevance Score: 81%
Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer
Expert Review of Anticancer Therapy, 10/21/09
Relevance Score: 81%
High-Throughput Cell-Based Screening of 4910 Known Drugs and Drug-like Small Molecules Identifies Disulfiram as an Inhibitor of Prostate Cancer Cell Growth
Clinical Cancer Research, 10/06/09
Relevance Score: 81%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Loss of expression of TIMP3 in clear cell renal cell carcinoma
European Journal of Cancer, 03/18/10
Primary Ewings sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin
International Journal of Clinical Oncology, 03/18/10
Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo
Journal of Cancer Research & Clinical Oncology, 03/18/10
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-Blind, Controlled Study of Losartan in Children with Proteinuria
Clinical Journal of the American Society of Nephrology, 03/19/10
Effect of Prenatal Dexamethasone on Postnatal Serum and Urinary Angiotensin II Levels
American Journal of Hypertension, 03/19/10
Sodium bicarbonate in preventing contrast nephropathy in patients at risk for volume overload: a randomized controlled trial
Journal of Nephrology, 03/18/10
Article Search
Sponsor


See Latest Articles


